Delivery Order SPE2DB22D3004-SPE2DB25FRY71
- Not listed
- The Defense Logistics Agency awarded a $2,327.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,745.76 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,493.20 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This order, issued on August 13, 2025, with completion targeted for August 14, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,276.46 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of July 25, 2025. The delivery order was issued on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.58 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam, a topical pharmaceutical product in a 10-gram formulation. This non-competitive delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed price contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,515.44 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for PROCTOFOAM-HC 1%-1% Foam in a 10-gram unit, valued at $1,445.61. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025. The award was made on a competitive basis without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters and a...
- The Defense Logistics Agency awarded a $5,030.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities, with an ultimate completion date of August 14, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,572.00 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam 10GM, a pharmaceutical product for medical supply needs. The contract carries a firm fixed price structure with no set-aside designation and was competitively awarded. The ultimate completion date is August 4, 2025, with the award issued on August 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam (10 grams) under a firm fixed price contract with a ceiling value of $29,765.92. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This is a non-set-aside delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY71Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,202.12 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This competitive award, with no set-aside designation, was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for the topical foam product exemplifies the company's role in fulfilling routine medical supply requirements through the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/12/25 |